Ningyan Zhang

University of Texas Medical School at Houston

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Kai Sun

Associate Professor (tenured)

The University of Texas Health Science Center at Houston

UNITED STATES

View details

Anil Sood

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

bin wu

Associate Professor

Nanyang Technological University (NTU)

SINGAPORE

View details

James Case

Washington University in St. Louis

UNITED STATES

View details

Zhiqiang An

The University of Texas Health Science Center at Houston

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ningyan Zhang

Research Interests

Explore related searches

Contact this professor

Articles (12)

Endotrophin as a Biomarker for Severe Acute Kidney Injury and Major Adverse Kidney Events

Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine

Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L

Endotrophin neutralization through targeted antibody treatment protects from renal fibrosis in a podocyte ablation model

Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets

Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma

A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins

A novel humanized Chi3l1 blocking antibody attenuates acetaminophen-induced liver injury in mice

Antibody therapeutics for epithelial ovarian cancer

Engineering antibody and protein therapeutics to cross the blood–brain barrier

Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth

Impairment of IgG Fc functions promotes tumor progression and suppresses NK cell antitumor actions.

Collaborators (5)

Kai Sun

Anil Sood

bin wu

James Case

Zhiqiang An

Make your next move.